This method revealed elevated plasma dsRNA levels in early MS, with dsRNA levels positively correlating with antiviral cytokines, particularly in patients with serological evidence of atypical EBV reactivation (anti-EBNA1 IgG+ and anti-EBNA1 IgM+). This evidence concerns the gene CD40LG and myeloid sarcoma.